SEVLENTIX Trademark

Trademark Overview

On Wednesday, December 18, 2019, a trademark application was filed for SEVLENTIX with the United States Patent and Trademark Office. The USPTO has given the SEVLENTIX trademark a serial number of 88731764. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 17, 2023. This trademark is owned by ESTEVE PHARMACEUTICALS, S.A.. The SEVLENTIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of Pain
sevlentix

General Information

Serial Number88731764
Word MarkSEVLENTIX
Filing DateWednesday, December 18, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 17, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of Pain

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, December 21, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameESTEVE PHARMACEUTICALS, S.A.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBarcelona 08038
ES
Party NameESTEVE PHARMACEUTICALS, S.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBarcelona 08038
ES

Trademark Events

Event DateEvent Description
Monday, July 17, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 17, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, December 31, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 30, 2022SOU EXTENSION 5 GRANTED
Tuesday, December 13, 2022SOU EXTENSION 5 FILED
Friday, December 30, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 13, 2022TEAS EXTENSION RECEIVED
Thursday, June 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 31, 2022SOU EXTENSION 4 GRANTED
Tuesday, May 31, 2022SOU EXTENSION 4 FILED
Tuesday, May 31, 2022TEAS EXTENSION RECEIVED
Thursday, November 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 23, 2021SOU EXTENSION 3 GRANTED
Tuesday, November 23, 2021SOU EXTENSION 3 FILED
Tuesday, November 23, 2021TEAS EXTENSION RECEIVED
Thursday, May 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 25, 2021SOU EXTENSION 2 GRANTED
Tuesday, May 25, 2021SOU EXTENSION 2 FILED
Tuesday, May 25, 2021TEAS EXTENSION RECEIVED
Saturday, December 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 3, 2020SOU EXTENSION 1 GRANTED
Thursday, December 3, 2020SOU EXTENSION 1 FILED
Thursday, December 3, 2020TEAS EXTENSION RECEIVED
Tuesday, June 16, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 17, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 17, 2020ASSIGNED TO EXAMINER
Saturday, December 21, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 21, 2019NEW APPLICATION ENTERED

Related Keywords

sevlentix pain treatment preparations pharmaceutical